Smoking Cessation Program in the Construction Sector

Sponsor
University of Miami (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06098144
Collaborator
Florida Department of Health (Other)
608
1
3
38.8
15.7

Study Details

Study Description

Brief Summary

The main objective of this study is to identify the optimal adaptive smoking cessation program for the construction sector in terms of effectiveness, cost-effectiveness, and potential implementation.

Condition or Disease Intervention/Treatment Phase
  • Drug: Nicoderm C-Q Gum
  • Behavioral: Tobacco Quit-line
  • Behavioral: Brief Behavioral Counseling
  • Behavioral: Intensive Behavioral Counseling
Phase 4

Study Design

Study Type:
Interventional
Anticipated Enrollment :
608 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Cluster-randomized clinical trialCluster-randomized clinical trial
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Expanding the Role of the Safety Manager to Implement a Workplace Smoking Cessation Program in the Construction Sector
Anticipated Study Start Date :
Dec 4, 2023
Anticipated Primary Completion Date :
Feb 28, 2027
Anticipated Study Completion Date :
Feb 28, 2027

Arms and Interventions

Arm Intervention/Treatment
Experimental: Tobacco Quit-line (TQL) Group

Participants will be referred to the TQL and will be followed up for up to 12 months.

Behavioral: Tobacco Quit-line
The TQL is free, and the TQL counselor will provide three phone counseling sessions lasting approximately 15 minutes to devise a specific plan to quit smoking and arrange the delivery of 4 to 12 weeks of NRT based on need. Participants will be advised to request nicotine gums instead of patches to accommodate their job circumstances.

Experimental: Brief Behavioral Counseling Group

Participants will receive one brief behavioral counseling session and be followed up for 12 months.

Drug: Nicoderm C-Q Gum
Participants will receive an 8-week supply of nicotine replacement treatment (NRT). Based on participants' self-report on the number of cigarettes smoked, these are the possible dosages of NRT gum (2 mg and 4 mg). Participants should not smoke and use the nicotine gum at the same time. Nicotine gum should only be used when cravings for cigarettes arise and should not be treated like regular chewing gum. It is not to be constantly chewed NRT will be distributed based on the treatment condition.

Behavioral: Tobacco Quit-line
The TQL is free, and the TQL counselor will provide three phone counseling sessions lasting approximately 15 minutes to devise a specific plan to quit smoking and arrange the delivery of 4 to 12 weeks of NRT based on need. Participants will be advised to request nicotine gums instead of patches to accommodate their job circumstances.

Behavioral: Brief Behavioral Counseling
The counseling session will discuss preparing to quit, coping with job-related stress, getting social support, the "5A's" for preventing relapse (Avoid, Alter, Alternatives, Anticipate, and Active), proper use of NRT, and last approximately 30 minutes.

Experimental: Intensive Behavioral Counseling Group

Participants will receive four behavioral counseling sessions and be followed up for 12 months.

Drug: Nicoderm C-Q Gum
Participants will receive an 8-week supply of nicotine replacement treatment (NRT). Based on participants' self-report on the number of cigarettes smoked, these are the possible dosages of NRT gum (2 mg and 4 mg). Participants should not smoke and use the nicotine gum at the same time. Nicotine gum should only be used when cravings for cigarettes arise and should not be treated like regular chewing gum. It is not to be constantly chewed NRT will be distributed based on the treatment condition.

Behavioral: Intensive Behavioral Counseling
Participants will receive four weekly counseling sessions which include information about how to quit, challenges, and short and long-term relapse prevention. Each session will last approximately 20 minutes.

Outcome Measures

Primary Outcome Measures

  1. Program Effectiveness Measure in Percentage [Up to 4 years]

    Will be collected as the difference in percentage of participants who quit smoking at the 12-month follow-up assessment between the three treatment groups.

  2. Program Cost-Effectiveness Measured by Number of U.S Dollars [Up to 4 years]

    Will be measured as the difference in the number of U.S. dollars between the three programs.

  3. Program Cost-Effectiveness Measured by Quality Adjusted Life Years [Up to 4 years]

    Will be measured by quality-adjusted life years defined as the difference in the number of years lived in perfect health between the three programs.

Secondary Outcome Measures

  1. Program's Implementation- Acceptability Measured by Likert Scale [Up to 4 years]

    Using the Acceptability of Intervention Measure, acceptability will be scored on a 5-point Likert scale, with higher scores indicating greater acceptability.

  2. Program's Implementation- Feasibility Measured by Likert Scale [Up to 4 years]

    Using the Feasibility of Intervention Measure, feasibility will be scored on a 5-point Likert scale, with higher scores indicating greater feasibility.

  3. Program's Implementation- Sustainability Measured by Likert Scale [Up to 4 years]

    Using the Intervention Sustainability Assessment Tool, sustainability will be scored on a 7-point Likert scale, with higher scores indicating greater sustainability.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
Company leaders:
  • ≥ 18 years

  • Involved in decision making

  • Willing to participate in the implementation development and evaluation

Safety Managers:
  • ≥ 18 years

  • Be a safety manager

  • No plans to leave the company within the next year

  • Bilingual

  • Willing to receive training in smoking cessation treatment

  • Willing to deliver the smoking cessation treatment to workers

Construction Workers:
  • ≥ 18 years

  • Have smoked 5 or more cigarettes daily for the past year

  • Willing to make a serious quit attempt in the next 30 days

  • Planning to stay in the company for the next 12 months

  • Own a telephone and plan to keep it active for the next 12 months

Exclusion Criteria:
Safety Managers:
  • Current cigarette smoker

Contacts and Locations

Locations

Site City State Country Postal Code
1 Don Soffer Clinical Research Center Miami Florida United States 33136

Sponsors and Collaborators

  • University of Miami
  • Florida Department of Health

Investigators

  • Principal Investigator: Taghrid Asfar, MD, tasfar@miami.edu

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Taghrid Asfar, Associate Professor, University of Miami
ClinicalTrials.gov Identifier:
NCT06098144
Other Study ID Numbers:
  • 20230549
First Posted:
Oct 24, 2023
Last Update Posted:
Oct 27, 2023
Last Verified:
Oct 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
Yes
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 27, 2023